- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Eur J Pharm Biopharm. 2016 Aug 25. pii: S0939-6411(16)30465-9. doi: 10.1016/j.ejpb.2016.08.012. [Epub ahead of print]
Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: effect of surface modification with chitosan and mannan.Li Z1, Xiong F1, He J2, Dai X1, Wang G3.
Author information
- 1College of Life Science, Hebei Normal University, NO.20 Road East of 2nd Ring South, Shijiazhuang City, Hebei Province 050024, People's Republic of China.
- 2College of Life Science, Hebei Normal University, NO.20 Road East of 2nd Ring South, Shijiazhuang City, Hebei Province 050024, People's Republic of China. Electronic address: [email protected].
- 3College of Environmental Science and Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, China. Electronic address: [email protected].
AbstractIn the present study, surface-functionalized, pH-responsive poly(lactic-co-glycolic acid) (PLGA) microparticles were investigated for nasal delivery of hepatitis B surface Antigen (HBsAg). pH-responsive PLGA, chitosan modified PLGA (CS-PLGA), mannan modified PLGA (MN-PLGA), mannan and chitosan co-modified PLGA (MN-CS-PLGA) microparticles were prepared utilizing a double-emulsion method. Antigen released rapidly from four types of microparticles at pH5.0 and pH 6.0, but slowly released at pH 7.4. Mannan and chitosan surface modification enhanced intracellular microparticle uptake by macrophages. Following intracellular macrophage antigen uptake, antigen release occurred in three different patterns: fast release from PLGA and MN-PLGA microparticles in endosomes/lysosomes, slow release from CS-PLGA microparticles in cytoplasm and a combination of fast release and slow release patterns from MN-CS-PLGA microparticles. Furthermore, chitosan coating modification increased the residence time of CS-PLGA and MN-CS-PLGA microparticles in the nasal cavity. In vivo immunogenicity studies indicated that MN-CS-PLGA microparticles induced stronger humoral and cell-mediated immune responses compared with PLGA, MN-PLGA and CS-PLGA microparticles. These results suggest that surface modification of pH-responsive PLGA microparticles with mannan and chitosan is a promising tool for nasal delivery of HBsAg.
Copyright © 2016. Published by Elsevier B.V.
KEYWORDS: Antigen intracellular release; Chitosan; Intranasal vaccination; Mannan; PLGA microparticles; pH-responsive
PMID:27569030DOI:10.1016/j.ejpb.2016.08.012
|
|